https://www.selleckchem.com/pr....oducts/danicamtiv-my
e of patients with heart failure. The trial has been recruiting patients since October 2017. TRIAL REGISTRATION NCT03321682. Registered on October 26, 2017.BACKGROUND With the rapid development of single-cell RNA sequencing technology, it is possible to dissect cell-type composition at high resolution. A number of methods have been developed with the purpose to identify rare cell types. However, existing methods are still not scalable to large datasets, limiting their utility. To overcome this limitation, we present a new sof
Like
Comment
Share
